Completed PHASE4 INTERVENTIONAL 2-arm NCT02959853

Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)

Sponsor: Baylor College of Medicine

Updated 10 times since 2017 Last updated: Jan 20, 2020 Started: Jun 30, 2016 Primary completion: Nov 20, 2018 Completion: Dec 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02959853, this PHASE4 trial focuses on Hypogonadism and Severe Obesity and remains completed. Sponsored by Baylor College of Medicine, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Feb 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Dec 2018 — Feb 2020 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor College of Medicine

Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States